It has been demonstrated that influencing EPHX1 activity or causing its dysregulation may lead to the occurrence of gynecological disorders such as pre-eclampsia, cervical cancer, and ovarian cancer. This evidence concerns the gene EPHX1 and ovarian carcinoma.